included a 6-week off-treatment follow-up period [5] [6] a design choice consistent with, though not explained by, that slow washout
Important Notes Practical considerations for consistent research preparation and recordkeeping
The phenomenon of clasmatodendrosis
Efecto del liraglutide en el control del peso en personas no diabticas con sobrepeso u obesidad (estudio SCALE)
Chronic glucocorticoid use, certain medications with myopathy as a rare side effect (such as statins or fluoroquinolones), and systemic illnesses can promote muscle catabolism
The Adverse Events in FDAs Review Three FAERS reports were discussed FDAs briefing describes reports in its Adverse Event Reporting System involving an injection-site reaction, shortness of breath, diffuse skin darkening, and gum darkening